159 related articles for article (PubMed ID: 27431352)
1. Sjögren Syndrome: Why Do Clinical Trials Fail?
Fox RI; Fox CM
Rheum Dis Clin North Am; 2016 Aug; 42(3):519-30. PubMed ID: 27431352
[TBL] [Abstract][Full Text] [Related]
2. Treatment Guidelines for Rheumatologic Manifestations of Sjögren's Syndrome: Use of Biologic Agents, Management of Fatigue, and Inflammatory Musculoskeletal Pain.
Carsons SE; Vivino FB; Parke A; Carteron N; Sankar V; Brasington R; Brennan MT; Ehlers W; Fox R; Scofield H; Hammitt KM; Birnbaum J; Kassan S; Mandel S
Arthritis Care Res (Hoboken); 2017 Apr; 69(4):517-527. PubMed ID: 27390247
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Sjögren's syndrome: current therapy and future directions.
Fox RI; Fox CM; Gottenberg JE; Dörner T
Rheumatology (Oxford); 2021 May; 60(5):2066-2074. PubMed ID: 31034046
[TBL] [Abstract][Full Text] [Related]
4. Issues related to clinical trials of oral and biologic disease-modifying agents for Sjögren's syndrome.
Carsons SE
Rheum Dis Clin North Am; 2008 Nov; 34(4):1011-23, x. PubMed ID: 18984419
[TBL] [Abstract][Full Text] [Related]
5. SER recommendations on the use of biological drugs in primary Sjögren's syndrome.
Andréu Sánchez JL; Fernández Castro M; Del Campo Fontecha PD; Corominas H; Narváez García FJ; Gómez de Salazar JR; Rua-Figueroa Í; Abad Hernández MÁ; Álvarez Rivas MN; Montes JDP; Francisco Hernández FM; Gantes Pedraza MÁ; Greco Merino MG; Hernández MV; Navarro Compán MV; Solarte JAP; Romero Bueno FI; Park HS; Sivera Mascaró F
Reumatol Clin (Engl Ed); 2019; 15(6):315-326. PubMed ID: 30683506
[TBL] [Abstract][Full Text] [Related]
6. Use of Biologics in Sjögren's Syndrome.
Nocturne G; Cornec D; Seror R; Mariette X
Rheum Dis Clin North Am; 2016 Aug; 42(3):407-17. PubMed ID: 27431344
[TBL] [Abstract][Full Text] [Related]
7. Rituximab therapy in primary Sjögren's syndrome.
Alcântara C; Gomes MJ; Ferreira C
Ann N Y Acad Sci; 2009 Sep; 1173():701-5. PubMed ID: 19758218
[TBL] [Abstract][Full Text] [Related]
8. Biologics in oral medicine: Sjogren syndrome.
O'Neill ID; Scully C
Oral Dis; 2013 Mar; 19(2):121-7. PubMed ID: 22497865
[TBL] [Abstract][Full Text] [Related]
9. Management of patients presenting with Sjogren's syndrome.
Venables PJ
Best Pract Res Clin Rheumatol; 2006 Aug; 20(4):791-807. PubMed ID: 16979538
[TBL] [Abstract][Full Text] [Related]
10. Biologics in Sjögren's syndrome.
Skarlis C; Marketos N; Mavragani CP
Pharmacol Res; 2019 Sep; 147():104389. PubMed ID: 31415917
[TBL] [Abstract][Full Text] [Related]
11. [Characteristics of keratoconjunctivitis sicca in Sjögren's disease and syndrome].
Safonova TN; Iudina IuV
Ter Arkh; 1988; 60(4):30-1. PubMed ID: 3394092
[TBL] [Abstract][Full Text] [Related]
12. [Current therapeutic options in Sjögren's syndrome].
Hansen A; Dörner T
Z Rheumatol; 2010 Feb; 69(1):19-24. PubMed ID: 20013285
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trial.
Meijer JM; Meiners PM; Vissink A; Spijkervet FK; Abdulahad W; Kamminga N; Brouwer E; Kallenberg CG; Bootsma H
Arthritis Rheum; 2010 Apr; 62(4):960-8. PubMed ID: 20131246
[TBL] [Abstract][Full Text] [Related]
14. Sjögren Syndrome in the Twenty-First Century.
Scofield RH
Rheum Dis Clin North Am; 2016 Aug; 42(3):xiii-xiv. PubMed ID: 27431355
[No Abstract] [Full Text] [Related]
15. Clinical manifestations and early diagnosis of Sjögren syndrome.
Kassan SS; Moutsopoulos HM
Arch Intern Med; 2004 Jun; 164(12):1275-84. PubMed ID: 15226160
[TBL] [Abstract][Full Text] [Related]
16. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
[TBL] [Abstract][Full Text] [Related]
17. Sjögren's syndrome: diagnosis and therapeutic challenges in the elderly.
Ng KP; Isenberg DA
Drugs Aging; 2008; 25(1):19-33. PubMed ID: 18184026
[TBL] [Abstract][Full Text] [Related]
18. New Treatment Guidelines for Sjögren's Disease.
Vivino FB; Carsons SE; Foulks G; Daniels TE; Parke A; Brennan MT; Forstot SL; Scofield RH; Hammitt KM
Rheum Dis Clin North Am; 2016 Aug; 42(3):531-51. PubMed ID: 27431353
[TBL] [Abstract][Full Text] [Related]
19. [Sjögren's syndrome].
Ernst D; Witte T
Dtsch Med Wochenschr; 2016 Apr; 141(8):544-50. PubMed ID: 27078243
[TBL] [Abstract][Full Text] [Related]
20. Primary Sjogren's syndrome: current and prospective therapies.
Thanou-Stavraki A; James JA
Semin Arthritis Rheum; 2008 Apr; 37(5):273-92. PubMed ID: 17714766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
